Quantitative Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
PCM
Quantitative Investment Management's JAZZ Position: Q3 2021 in Review
Quantitative Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2021, closing a stake of 8,782 shares — an estimated $1.56M sold.
Quantitative Investment Management first reported a position in JAZZ in Q2 2013 and held it in 15 quarters. The position peaked at $9.58M in Q4 2019. 455 funds tracked by Wall St. Rank hold JAZZ as of Q3 2021.
- Quantitative Investment Management reported no remaining Jazz Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
- Quantitative Investment Management sold 8,782 Jazz Pharmaceuticals shares in Q3 2021, an estimated $1.56M.
- Quantitative Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 15 quarters.
- Quantitative Investment Management's Jazz Pharmaceuticals position peaked at $9.58M in Q4 2019.
- 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2021.
Based on Quantitative Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.